Cargando…
One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3
AIMS: To evaluate 1-year outcome after transcatheter aortic valve implantation (TAVI) using the SAPIEN 3 (S3) prosthesis with emphasis on the composite endpoints “clinical efficacy after 30 days” and “time-related valve safety” proposed by the updated Valve Academic Research Consortium (VARC-2). MET...
Autores principales: | Pellegrini, Costanza, Rheude, Tobias, Trenkwalder, Teresa, Mayr, N. Patrick, Joner, Michael, Kastrati, Adnan, Schunkert, Heribert, Husser, Oliver, Hengstenberg, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805964/ https://www.ncbi.nlm.nih.gov/pubmed/31049679 http://dx.doi.org/10.1007/s00392-019-01461-7 |
Ejemplares similares
-
One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019) -
Spotlight on the SAPIEN 3 transcatheter heart valve
por: Rheude, Tobias, et al.
Publicado: (2018) -
Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement
por: Lachmann, Mark, et al.
Publicado: (2022) -
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials
por: Pellegrini, Costanza, et al.
Publicado: (2020) -
Comparison of latest generation supra-annular and intra-annular self-expanding transcatheter heart valves
por: Pellegrini, Costanza, et al.
Publicado: (2020)